Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024
BOSTON and LONDON, April 22, 2024 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a......
Free CME-Certified, On-Demand Webinar: Earn up to 1.0 AMA PRA Category 1 Credit™
Narcolepsy is a high-burden sleep disorder marked by heterogeneous presentations that can be subtle, difficult to detect, and (sometimes) even more difficult to manage. Join distinguished experts, Dr Kiran Maski and Dr Clete Kushida, as they clarify the path to narcolepsy diagnosis and treatment, including novel therapies that can help patients restore the balance between wake and sleep.
Expires: December 2024
Narcolepsy affects 1 in every 2,000 Americans and 3 million people worldwide.
It is estimated that up to 50% of patients with Narcolepsy may be undiagnosed.
Typical onset of Narcolepsy is between the ages of 10 and 20 years old, but can occur in early childhood.
On average, patients have 6 physician visits before receiving a Narcolepsy diagnosis.
Online Support GroupsFree, online support groups worldwide for people with Narcolepsy and their families. |
National SummitThis one-day summit is for people with Narcolepsy, their families, educators, clinicians and researchers. |
Clinical TrialsPatient engagement in clinical trials help find new ways to treat individuals with Narcolepsy. |
Annual Family WeekendChildren & Teens with Narcolepsy can meet others experiencing the same symptoms and challenges. |
Join Our TeamDo you share our passion for advocating on behalf of those with Narcolepsy? |
BOSTON and LONDON, April 22, 2024 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a......
PLYMOUTH MEETING, Pa., April 11, 2024 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today......
DUBLIN, April 9, 2024 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced positive topline results from the narcolepsy......
Join us on April 24th at 2pm ET for “Canada: Narcolepsy Medications & Access to......